Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Fake 14.5 bid back again

<< Previous

Bullboard Posts

Next >>

Comment by dooneryon Nov 30, 2022 11:02am

170 Views

Post# 35139761

RE:Fake 14.5 bid back again

its not a fake bid you idiot,,same thing is going on in germany..All we shareholders need to to do is band together and STOP SELLING SHARES !!!!!!If you dont get it ask Biorun he could explain,,even to you.Stop bashing start some POSITIVE dialogue here PLEASE ,ON THIS SITE.G L T A

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant